These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 20729872
1. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Nair S, Barve A, Khor TO, Shen GX, Lin W, Chan JY, Cai L, Kong AN. Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872 [Abstract] [Full Text] [Related]
2. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Nair S, Hebbar V, Shen G, Gopalakrishnan A, Khor TO, Yu S, Xu C, Kong AN. Pharm Res; 2008 Feb; 25(2):387-99. PubMed ID: 17657594 [Abstract] [Full Text] [Related]
3. Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation. Zhang C, Su ZY, Khor TO, Shu L, Kong AN. Biochem Pharmacol; 2013 May 01; 85(9):1398-404. PubMed ID: 23416117 [Abstract] [Full Text] [Related]
4. Modulation of NRF2 and UGT1A expression by epigallocatechin-3-gallate in colon cancer cells and BALB/c mice. Zhang ZM, Yang XY, Yuan JH, Sun ZY, Li YQ. Chin Med J (Engl); 2009 Jul 20; 122(14):1660-5. PubMed ID: 19719968 [Abstract] [Full Text] [Related]
5. Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells. Pei Y, Wu B, Cao Q, Wu L, Yang G. Toxicol Appl Pharmacol; 2011 Dec 15; 257(3):420-8. PubMed ID: 22005276 [Abstract] [Full Text] [Related]
6. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Xu C, Shen G, Chen C, Gélinas C, Kong AN. Oncogene; 2005 Jun 30; 24(28):4486-95. PubMed ID: 15856023 [Abstract] [Full Text] [Related]
7. ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells. Xu C, Shen G, Yuan X, Kim JH, Gopalkrishnan A, Keum YS, Nair S, Kong AN. Carcinogenesis; 2006 Mar 30; 27(3):437-45. PubMed ID: 16272172 [Abstract] [Full Text] [Related]
8. Comparison of (-)-epigallocatechin-3-gallate elicited liver and small intestine gene expression profiles between C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Shen G, Xu C, Hu R, Jain MR, Nair S, Lin W, Yang CS, Chan JY, Kong AN. Pharm Res; 2005 Nov 30; 22(11):1805-20. PubMed ID: 16132347 [Abstract] [Full Text] [Related]
9. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. Chen H, Landen CN, Li Y, Alvarez RD, Tollefsbol TO. Exp Cell Res; 2013 Mar 10; 319(5):697-706. PubMed ID: 23333498 [Abstract] [Full Text] [Related]
10. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Hu R, Xu C, Shen G, Jain MR, Khor TO, Gopalkrishnan A, Lin W, Reddy B, Chan JY, Kong AN. Cancer Lett; 2006 Nov 18; 243(2):170-92. PubMed ID: 16516379 [Abstract] [Full Text] [Related]
11. Nrf2 activation attenuates both orthodontic tooth movement and relapse. Kanzaki H, Shinohara F, Itohiya-Kasuya K, Ishikawa M, Nakamura Y. J Dent Res; 2015 Jun 18; 94(6):787-94. PubMed ID: 25795629 [Abstract] [Full Text] [Related]
12. Nrf2 sensitizes prostate cancer cells to radiation via decreasing basal ROS levels. Liu M, Yao XD, Li W, Geng J, Yan Y, Che JP, Xu YF, Zheng JH. Biofactors; 2015 Jun 18; 41(1):52-7. PubMed ID: 25728635 [Abstract] [Full Text] [Related]
13. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates. Saw CL, Cintrón M, Wu TY, Guo Y, Huang Y, Jeong WS, Kong AN. Biopharm Drug Dispos; 2011 Jul 18; 32(5):289-300. PubMed ID: 21656528 [Abstract] [Full Text] [Related]
14. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling. Oh CJ, Kim JY, Min AK, Park KG, Harris RA, Kim HJ, Lee IK. Free Radic Biol Med; 2012 Feb 01; 52(3):671-682. PubMed ID: 22155056 [Abstract] [Full Text] [Related]
15. Candidate dietary phytochemicals modulate expression of phase II enzymes GSTP1 and NQO1 in human lung cells. Tan XL, Shi M, Tang H, Han W, Spivack SD. J Nutr; 2010 Aug 01; 140(8):1404-10. PubMed ID: 20554899 [Abstract] [Full Text] [Related]
16. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane. Su ZY, Zhang C, Lee JH, Shu L, Wu TY, Khor TO, Conney AH, Lu YP, Kong AN. Cancer Prev Res (Phila); 2014 Mar 01; 7(3):319-29. PubMed ID: 24441674 [Abstract] [Full Text] [Related]
17. Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. Kweon MH, Adhami VM, Lee JS, Mukhtar H. J Biol Chem; 2006 Nov 03; 281(44):33761-72. PubMed ID: 16950787 [Abstract] [Full Text] [Related]
18. Transcriptome analysis reveals a dynamic and differential transcriptional response to sulforaphane in normal and prostate cancer cells and suggests a role for Sp1 in chemoprevention. Beaver LM, Buchanan A, Sokolowski EI, Riscoe AN, Wong CP, Chang JH, Löhr CV, Williams DE, Dashwood RH, Ho E. Mol Nutr Food Res; 2014 Oct 03; 58(10):2001-13. PubMed ID: 25044704 [Abstract] [Full Text] [Related]
19. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW. Int J Oncol; 2004 Jan 03; 24(1):187-92. PubMed ID: 14654956 [Abstract] [Full Text] [Related]
20. Structural influence of isothiocyanates on the antioxidant response element (ARE)-mediated heme oxygenase-1 (HO-1) expression. Prawan A, Keum YS, Khor TO, Yu S, Nair S, Li W, Hu L, Kong AN. Pharm Res; 2008 Apr 03; 25(4):836-44. PubMed ID: 17657593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]